South Korean stocks ended lower Friday as investors took a breather amid signals of tighter monetary policy in the United States. The South Korean currency weakened against the US dollar.
The benchmark Korea Composite Stock Price Index shed 6.54 points, or 0.31 percent, to close at 2,086.09. Trading volume was relatively light at 292.94 million shares worth 5.15 trillion won ($4.57 billion), with losers outnumbering winners 463 to 363.
Institutions unloaded shares worth 288.3 billion won, offsetting the buying by retail and foreign investors who scooped up 225 billion won and 31.3 billion won of local shares, respectively.
After opening a tad higher, the index fluctuated between positive and negative territory throughout the session. Wall Street also finished mixed, with the Dow Jones industrial average edging up 0.04 percent and the Nasdaq composite falling 0.25 percent following strong gains in the previous session over the post-election relief.
“After the US central bank’s meeting, the US dollar and Treasury yields rose, which caused a weakening of US shares,” said Seo Sang-young, an expert at Kiwoom Securities.
On Thursday (US time), the Federal Reserve decided to stand pat on interest rates but maintained its previous stance that it would pull the trigger again next month in a move to continue to tighten monetary policy.
“Such a plan would add greater volatility to the market, though any serious downturn would be unlikely,” he forecast.
Bio shares tumbled to drag down the index. Pharmaceutical giant Celltrion sank 3.77 percent to 229,500 won, and Samsung BioLogics skidded 4.29 percent to 368,000 won on suspicions over its alleged accounting fraud in 2015.
Chemicals also lost ground. LG Chem shed 2.24 percent to 327,500 won, and S-Oil plunged 4.17 percent to 115,000 won. LG Household & Health Care also slumped 4.8 percent to 1,110,000 won.
Tech shares overall traded higher, though top-cap ones